Emerging Evidence of the Impact of Kidney Disease on Drug Metabolism and Transport

The clinical pharmacokinetic consequences of kidney disease on drug disposition. CYP, cytochrome P450; MRP, multidrug resistance–associated protein; NAT, N-acetyltransferase; OATP, organic anion-transporting polypeptides; P-gp, P-glycoprotein.